Insider · CIK 0001509688

Schorno Dean L

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001509688

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+694 sh	$12.70	+$8,813.8	79,056
2026-09-02	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+620 sh	$18.70	+$11.6K	79,676
2026-09-02	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,000 sh	$24.20	+$48.4K	81,676
2026-09-02	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,286 sh	$24.20	+$31.1K	82,962
2026-09-02	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−694 sh	—	—	12,824
2026-09-02	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−620 sh	—	—	9,012
2026-09-02	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,000 sh	—	—	7,999
2026-09-02	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,286 sh	—	—	15,867
2026-09-01	RIGLRIGEL PHARMACEUTICALS INCF Tax Payment	EVP & Chief Financial Officer	FTax Payment	−928 sh	$47.50	−$44.1K	78,362
2026-06-17	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+7,394 sh	—	—	7,394
2026-06-01	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,200 sh	$18.70	+$22.4K	77,537
2026-06-01	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,181 sh	$12.70	+$27.7K	79,718
2026-06-01	RIGLRIGEL PHARMACEUTICALS INCF Tax Payment	EVP & Chief Financial Officer	FTax Payment	−928 sh	$29.86	−$27.7K	78,790
2026-06-01	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,200 sh	—	—	9,632
2026-06-01	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,181 sh	—	—	13,518
2026-02-17	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP & Chief Financial Officer	AAward	+20.6K sh	—	—	76,337
2026-02-10	RIGLRIGEL PHARMACEUTICALS INCF Tax Payment	EVP & Chief Financial Officer	FTax Payment	−3,546 sh	$34.62	−$123K	55,701
2026-02-02	RIGLRIGEL PHARMACEUTICALS INCF Tax Payment	EVP & Chief Financial Officer	FTax Payment	−5,488 sh	$36.01	−$198K	59,247
2025-12-22	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,987 sh	$20.00	+$39.7K	59,722
2025-12-22	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,846 sh	$24.20	+$68.9K	62,568
2025-12-22	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,667 sh	$18.70	+$31.2K	64,235
2025-12-22	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,987 sh	—	—	14,262
2025-12-22	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,846 sh	—	—	17,153
2025-12-22	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,667 sh	—	—	10,832
2025-09-15	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+7,394 sh	—	—	7,394
2025-03-17	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+5,625 sh	—	—	5,625
2025-03-17	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+7,850 sh	—	—	7,850
2025-02-05	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Financial Officer	SSale	−1,734 sh	$21.93	−$38K	57,235
2025-02-04	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Financial Officer	SSale	−2,036 sh	$20.92	−$42.6K	58,969
2025-01-29	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP & Chief Financial Officer	AAward	+19.7K sh	—	—	61,005
2025-01-29	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+14.8K sh	—	—	14,788
2024-11-25	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+6,250 sh	—	—	6,250
2024-08-30	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+10K sh	—	—	10,000
2024-02-28	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+62.5K sh	—	—	62,500
2024-02-28	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+78.5K sh	—	—	78,500
2024-02-05	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Financial Officer	SSale	−7,027 sh	$1.14	−$8,010.78	402,891
2024-02-02	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Financial Officer	SSale	−5,601 sh	$1.13	−$6,326.89	409,918
2024-01-23	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP & Chief Financial Officer	AAward	+209K sh	—	—	415,519
2024-01-23	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+157K sh	—	—	157,000
2023-02-02	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Financial Officer	SSale	−5,389 sh	$1.66	−$8,946.279	196,519
2023-01-26	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP & Chief Financial Officer	AAward	+63K sh	—	—	201,908
2023-01-26	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+50K sh	—	—	100,000
2023-01-26	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+125K sh	—	—	125,000
2022-12-28	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+50K sh	—	—	50,000
2022-09-14	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+81.3K sh	—	—	81,250
2022-01-24	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP & Chief Financial Officer	AAward	+50K sh	—	—	128,908
2022-01-24	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+100K sh	—	—	100,000
2021-11-04	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+81.3K sh	—	—	81,250
2021-04-01	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+50K sh	—	—	50,000
2021-01-27	RIGLRIGEL PHARMACEUTICALS INC · Stock Option(right to buy)A Award	EVP & Chief Financial Officer	AAward	+113K sh	—	—	112,500

Recent filings

Accepted (ET)
Sep 34
Schorno Dean L0000905148-26-004080
SEC(opens sec.gov)
Jun 224
Schorno Dean L0000905148-26-003036
SEC(opens sec.gov)
Jun 34
Schorno Dean L0000905148-26-002811
SEC(opens sec.gov)
Feb 194
Schorno Dean L0000905148-26-000952
SEC(opens sec.gov)
Feb 124
Schorno Dean L0000905148-26-000678
SEC(opens sec.gov)
Feb 44
Schorno Dean L0000905148-26-000497
SEC(opens sec.gov)
Dec 294
Schorno Dean L0000905148-25-004492
SEC(opens sec.gov)

Companies

Address

RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080